Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Telomir Pharmaceuticals

TELO

1.0602.75% ( -0.030 )

Closed: Aug 17, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Telomir Pharmaceuticals (NASDAQ:TELO) Releases Quarterly Earnings Results
Market Beat·Aug 13 at 05:56 PM
- Telomir Pharmaceuticals issued its quarterly earnings data, reporting an earnings per share of ($0.79) for the quarter. - The company's stock traded down $0.06 to reach $1.05, with a market capitalization of $72.22 million. - Institutional investors and hedge funds adjusted their holdings in the company, which currently holds an average analyst rating of "Hold".
TELO-2.75%BAC-0.93%
Telomir net loss narrows to $1.72 million in Q2 FY26; revenue flat at no revenue
PUBT·Aug 13 at 04:12 PM
TELO-2.75%
Telomir plans Phase 1/2 trial of Telomir-Zn in triple-negative breast cancer after preclinical publication
PUBT·Aug 10 at 07:06 AM
TELO-2.75%
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga_article·Aug 4 at 04:06 PM
RIGL-0.31%AMIX-6.57%
A Microcosm of 2026: From Pawnshop Booms to High-Stakes Tech Gambles
Global Report·Jul 29 at 04:18 AM
NRT-2.13%ONON-2.82%
Telomir Pharmaceuticals announces annual shareholder meeting via virtual webcast
PUBT·Jul 28 at 04:00 PM
TELO-2.75%
Tesla Inc Stock (TSLA) Moved Down by 12.68% on Jul 23: Facts Behind the Movement
TradingKey·Jul 23 at 09:19 AM
- Tesla Inc (TSLA) shares fell by 12.68% following disappointing second-quarter earnings, with a contraction in core automotive gross margin. - The decline has been attributed to investors' concerns over the company's aggressive pricing strategy, uncertain timeline for autonomous driving advancements, and shifting macroeconomic conditions affecting high-growth tech stocks. - Analysts have revised price targets downwards, signaling potential volatility ahead as Tesla works to stabilize margins and clarify its strategic direction.
TSLA-0.87%TSL-1.12%
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga_article·Jul 21 at 12:05 PM
TELO-2.75%CPHI-4.42%
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Down 17.2% - Here's Why
Market Beat·Jul 21 at 01:20 AM
- Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) experienced a 17.2% drop in share price during mid-day trading, reaching a low of $0.8885 before closing at $0.9192. - Analysts have given the stock ratings that include one Buy, one Hold, and one Sell, with the average rating being Hold, while Weiss Ratings reiterated a "sell" rating. - The company, focused on therapies for cardiometabolic and fibrotic diseases, reported a quarterly earnings per share of ($0.03), surpassing estimates by $0.04, and has seen increased institutional investment.
TELO-2.75%BAC-0.93%
Telo Genomics reports positive interim data for blood test predicting multiple myeloma relapse risk
PUBT·Jul 16 at 06:02 AM
TELO-2.75%
Pebble Flow electric RV towed by TELO’s MINI-sized electric truck
Electrek·Jul 14 at 11:10 AM
TELO-2.75%
Telo Genomics files US provisional patent for TeloView liquid biopsy MRD algorithm in multiple myeloma
PUBT·Jul 9 at 06:02 AM
TELO-2.75%
Automakers pivot to smaller EV pickups as big trucks falter
MSN·Jun 24 at 04:59 AM
- Full-size electric trucks struggle with range loss when towing, leading to poor sales due to high costs and impracticality for many buyers. - Automakers like Ford are pivoting towards compact, efficient EV pickups aimed at lower prices and urban use. - New startups such as Slate and Telo are launching minimalist compact EV trucks to capture the interest of cost-conscious urban drivers.
F-B-0.12%FORD0.00%